Clinical Report: Exploring Neurotechnology from User Perspectives
Background
Neurotechnology serves as a bridge between the nervous system and technological devices, with applications spanning medical, commercial, and military sectors. The market for neurotechnology is rapidly expanding, projected to reach approximately USD 38.17 billion by 2032. However, ethical and regulatory frameworks have not kept pace with this growth, leading to significant concerns regarding user safety and support.
Data Highlights
Neurotechnology market value reached USD 12.82 billion in 2022 and is projected to reach approximately USD 38.17 billion by 2032. The global neurostimulation devices market was valued at USD 6 billion in 2021, expected to reach USD 14 billion by 2030.
Key Findings
Neurotechnology market value reached USD 12.82 billion in 2022.
Projected market growth to USD 38.17 billion by 2032.
Global neurostimulation devices market valued at USD 6 billion in 2021, expected to reach USD 14 billion by 2030.
Inadequate patient care and market failures evidenced by cases like Second Sight.
UNESCO's 2025 declaration calls for ethical principles in neurotechnology to be incorporated into national law.
Clinical Implications
Healthcare professionals should be aware of the ethical challenges and regulatory gaps in neurotechnology. There is a need for improved communication and support structures for users, particularly those involved in clinical trials.
Conclusion
The rapid advancement of neurotechnology necessitates a focus on ethical standards and user needs to ensure responsible innovation and societal benefit.
by Danesh Ashouri, Ludwig Weh, Vera Borrmann, Christopher Coenen, Eva Maria Kraft, Viviana Loufs, Wenzel Mehnert, Paula Muhr, Oliver Müller, Melike Şahinol, Markus Schmidt, Günter Seyfried, Kai Soedibjo, Ian Erik Stewart, Gregor Wolbring, Sandra Youssef, Thomas Stieglitz
